Bioharvest Sciences (BHST) Receivables (2023 - 2025)

Bioharvest Sciences' Receivables history runs 3 years deep, the most recent figure standing at $2.0 million for Q4 2025.

• On a quarterly basis, Receivables rose 9.39% year-over-year to $2.0 million in Q4 2025; TTM through Dec 2025 was $2.0 million, a 9.39% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, up 22.64% from the prior year.
• Receivables declined to $2.0 million in Q4 2025 per BHST's latest filing, from $2.4 million in the prior quarter.
• Across five years, Receivables topped out at $2.5 million in Q2 2025 and bottomed at $1.2 million in Q4 2023.
• The 3-year median for Receivables is $2.0 million (2025), against an average of $1.9 million.
• Biggest YoY gain for Receivables was 62.74% in 2025; the steepest drop was 9.39% in 2025.
• Year by year, Receivables stood at $1.2 million in 2023, then surged by 47.12% to $1.8 million in 2024, then grew by 9.39% to $2.0 million in 2025.
• Per Business Quant, the three latest BHST Receivables figures stand at $2.0 million (Q4 2025), $2.4 million (Q3 2025), and $2.5 million (Q2 2025).